Intracardiac and extracardiac markers of inflammation during atrial fibrillation

Heart Rhythm. 2010;7(2):149-54. doi: 10.1016/j.hrthm.2009.10.004. Epub 2009 Oct 12.

Abstract

Background: A decrease in inflammation after cure of atrial arrhythmias suggests that such arrhythmias are proinflammatory, and lower inflammatory marker levels in the coronary sinus suggest that atrial arrhythmias result in intracardiac appropriation of inflammatory cytokines.

Objective: The purpose of this study was to investigate the effect of atrial fibrillation on inflammatory markers drawn from intracardiac and extracardiac chambers.

Methods: We performed a case-control study of 167 AF patients and 207 controls. Blood from intracardiac and extracardiac sites was obtained from a subset of patients undergoing curative AF ablation (n = 46).

Results: No significant differences in C-reactive protein (CRP) or interleukin-6 (IL-6) levels were seen between patients with and those without a history of AF. Both levels were significantly higher when blood was drawn during AF than during sinus rhythm: median CRP 3.1 mg/dL (interquartile range [IQR] 1.0-6.0) versus 1.7 mg/dL (IQR 0.7-3.9, P = .0005); median IL-6 2.3 ng/mL (IQR 1.5-3.9) versus 1.5 ng/mL (IQR 0.7-2.5, P = .007). This finding persisted after adjusting for potential confounders. AF ablation patients in AF exhibited a positive median left atrial minus coronary sinus gradient CRP (0.3 mg/dL, IQR -0.03-1.1), whereas those in sinus rhythm had a negative median left atrial minus coronary sinus gradient CRP (-0.2, IQR -0.8-[-0.02], P = .01). Femoral artery minus femoral vein gradients in AF versus sinus rhythm did not show any differences.

Conclusion: AF at the time of the blood draw, rather than a history of AF, was independently associated with inflammation. Differences in transcardiac gradients suggest that AF results in sequestration of inflammatory cytokines in the heart.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Atrial Fibrillation / blood*
  • Atrial Fibrillation / therapy
  • Biomarkers / blood*
  • C-Reactive Protein / metabolism*
  • Case-Control Studies
  • Chi-Square Distribution
  • Comorbidity
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Humans
  • Inflammation / blood
  • Interleukin-6 / blood*
  • Logistic Models
  • Male
  • Middle Aged
  • Statistics, Nonparametric

Substances

  • Biomarkers
  • Interleukin-6
  • C-Reactive Protein